Trial Profile

Safety and Pharmacokinetics Study of Multiple Dose Administration of Sifuvirtide in HIV-infected volunteers (FS0103).

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sifuvirtide (Primary)
Indications HIV infections
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

21 May 2012 Additional company (Beijing Kaokerui Pharma) added in association as reported by Chinese Clinical Trial Register.
21 May 2012 Actual end date changed from Sep 2006 to 31 Jul 2007 as reported by Chinese Clinical Trial Register.
21 May 2012 Planned number of patients changed from 52 to 24 as reported by Chinese Clinical Trial Register record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com